Following the UK’s exit from the European Union, the regulatory framework for placing medical devices on the Great Britain market has undergone significant change. The UK Conformity Assessed (UKCA) marking is now the primary route for demonstrating compliance with UK medical device regulations and enabling legal market access in England, Scotland, and Wales. While the current UK Medical Devices Regulations 2002 (UK MDR) are still largely based on legacy EU Directives, the regulatory environment is evolving, with future reforms expected to increase alignment with global best practice while introducing UK-specific requirements. For medical device manufacturers, particularly startups and growing SMEs, navigating UKCA requirements can be confusing. Transitional arrangements, changing deadlines, and uncertainty around future regulation make it difficult to plan with confidence. Our UKCA consulting services are designed to cut through that complexity — helping you understand what is required today, prepare for what is coming next, and maintain uninterrupted access to the UK market.
We support clients in determining the appropriate device classification based on intended purpose, risk profile, and applicable UK rules. This includes advising on borderline and complex cases where classification may differ between the UK and EU or where future regulatory changes may impact conformity assessment routes. Beyond classification, we develop proportionate UKCA regulatory strategies that align with your broader business and market plans. For startups and scale-ups, this often means balancing UK market access against EU and global regulatory priorities. We help define conformity assessment pathways, identify Approved Body involvement where required, and plan certification activities in a way that supports commercial timelines and reduces regulatory risk.
For companies with existing CE-marked devices, a structured gap assessment is a critical step toward UKCA compliance. We perform targeted gap analyses to assess your current technical documentation, quality system, and post-market processes against UKCA and UK MDR requirements, as well as emerging UK regulatory expectations. Our gap assessments are practical and action-oriented. Rather than generating long lists of theoretical deficiencies, we focus on identifying what genuinely needs to be updated, remediated, or generated to support UKCA marking. This includes assessing risk management files, clinical evidence, labelling, vigilance procedures, and UK-specific obligations such as MHRA registration. The output is a clear, prioritised remediation plan that allows you to allocate resources effectively and move forward with confidence.
We support clients with the compilation, update, and review of UKCA-compliant technical documentation, ensuring it is structured, consistent, and suitable for assessment by UK Approved Bodies. This includes authoring and updating core technical file components, aligning existing CE documentation with UK requirements, and ensuring clear traceability across risk management, clinical evidence, and performance claims. For companies with limited internal regulatory capacity, we can lead documentation development end-to-end. For more established teams, we provide expert review, targeted updates, and strategic input to strengthen existing files. Our goal is to ensure your technical documentation not only meets current UKCA requirements, but is also robust enough to adapt as the UK regulatory framework continues to evolve.
Engaging with UK Approved Bodies is a key part of the UKCA process, and capacity constraints can present real challenges for manufacturers. We support clients in identifying suitable Approved Bodies based on device type, classification, and business priorities. Our team assists with application preparation, submission planning, and management of assessment activities to keep projects on track. We also support ongoing interactions with UK regulators, including MHRA registration, vigilance reporting, and post-market obligations. Acting as an extension of your team, we help interpret feedback, respond to questions, and maintain clear communication throughout the certification lifecycle. For startups and SMEs new to the UKCA process, this support provides structure, predictability, and reassurance at a time of regulatory uncertainty.
